Perspective Therapeutics (CATX) announced the appointment of Joel Sendek as the Company’s CFO. Sendek previously served as CFO at four biotech companies: Dewpoint Therapeutics, Sema4, Spero Therapeutics, and Forward Pharma. Sendek is succeeding Juan Graham, who will be leaving the Company.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics management to meet with Oppenheimer
- Perspective Therapeutics Appoints Maya Martinez-Davis to Board
- Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
- Perspective Therapeutics Updates on Radiopharmaceutical Advancements
- Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics